NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
Follow-Up Questions
NovaBay Pharmaceuticals Inc 的 CEO 是誰？
Mr. Justin Hall 是 NovaBay Pharmaceuticals Inc 的 Chief Executive Officer，自 2015 加入公司。
NBY 股票的價格表現如何？
NBY 的當前價格為 $1.92，在上個交易日 decreased 了 1.03%。
NovaBay Pharmaceuticals Inc 的主要業務主題或行業是什麼？
NovaBay Pharmaceuticals Inc 屬於 Pharmaceuticals 行業，該板塊是 Health Care
